Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

Investigators conducted a retrospective review that spanned 10 years with the goals of describing the clinical ...

Lung cancer remains the leading cause of cancer-related deaths globally, with cigarette smoking as its primary driver.

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...

Cancer is one of the leading causes of death worldwide, and many people often overlook or dismiss early warning signs. While ...

The stigma of lung cancer is problematic and could influence smokers to feel guilty, ignore symptoms ... treatments for an ever-expanding range of tumor types and genetic mutations.” ...

I started feeling even more exhausted than usual. I also had lower back and abdominal pain and bloating, but I shrugged it off because women just have to deal with that..." ...

Head and neck cancers affect the mouth, throat, larynx, and more, with early detection being crucial for better survival chances. Key early symptoms include persistent sore throat, voice changes, ...

a family history of cancer, or advanced age (older than 60 years) have an increased risk of developing a neuroendocrine tumor. 7 Some patients with neuroendocrine tumors have no symptoms.

As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...

7.“A few months after getting H1N1 flu, I started sleeping for very long periods of time (up to 20 hours, sometimes two days ...

Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX® ) and mFOLFOX6 ...